Skip to content
OUR SOLUTIONS
triSure
SPOT-MAS
K-TRACK | K-4CARE
ABOUT US
Our Vision
Our Laboratories
Leadership Team
Contact us
OUR SCIENCE
Publications & Abstracts
NEWS & INSIGHTS
OUR SOLUTIONS
triSure
SPOT-MAS
K-TRACK | K-4CARE
ABOUT US
Our Vision
Our Laboratories
Leadership Team
Contact us
OUR SCIENCE
Publications & Abstracts
NEWS & INSIGHTS
Cost-effective shallow genome-wide sequencing for profiling plasma cfDNA signatures to enhance lung cancer detection
March 25, 2025
SPOT-MAS
Prev
Previous Article
Prospective validation study: a non-invasive circulating tumor DNA-based assay for simultaneous early detection of multiple cancers in asymptomatic adults
Next Article
Gene Solutions Leads the Way in Cancer Early Detection with Asia’s First Clinical Validated Multi-Cancer Blood Test
Next